NCT07470853
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT07470853
Title A Study of MUC16-Directed Antibody Drug Conjugate HWK-016 in Participants With Advanced Solid Tumors.
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Whitehawk Therapeutics, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA

Facility Status City State Zip Country Details
University of Arkansas - Winthrop P. Rockefeller Cancer Institute NOT_YET_RECRUITING Little Rock Arkansas 72205 United States Details
START - Los Angeles RECRUITING Los Angeles California 90025 United States Details
SCRI - Florida Cancer Specialists NOT_YET_RECRUITING Sarasota Florida 34232 United States Details
St. Francis Medical Center (OSF Healthcare) NOT_YET_RECRUITING Peoria Illinois 61637 United States Details
Karmanos Cancer Center NOT_YET_RECRUITING Detroit Michigan 48201 United States Details
Start - Ny RECRUITING Lake Success New York 11042 United States Details
Memorial Sloan Kettering Cancer Center NOT_YET_RECRUITING New York New York 07920 United States Details
Atrium Health - Wake Forest NOT_YET_RECRUITING Charlotte North Carolina 282204 United States Details
Ohio State University Wexner Medical Center NOT_YET_RECRUITING Columbus Ohio 43210 United States Details
SCRI - Sydney Kimmel Cancer Center - Jefferson Health NOT_YET_RECRUITING Philadelphia Pennsylvania 19107 United States Details
SCRI - Mary Crowley Cancer Research NOT_YET_RECRUITING Dallas Texas 75230 United States Details
START Mountain RECRUITING Salt Lake City Utah 84119 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field